BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.600
+0.100 (6.67%)
At close: Jan 9, 2026
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 41.77 million as of January 9, 2026. Its market cap has decreased by -44.88% in one year.
Market Cap
41.77M
Enterprise Value
-4.03M
Revenue
42.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 41.77M, an increase of 25,523.70%. That is a compound annual growth rate of 34.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 41.77M | - |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.47B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.49B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 664.14M |